A new study published in the Journal of Drug Design, Development and Therapy has shown the effectiveness of Zolav®, a new antibiotic cream developed by the Australian Pharmaceutical Research Company, Boulos & Cooper Pharmaceuticals in conjunction with AXD Pty Ltd, an Australian private Consulting Firm.
Zolav® is seen as a low-risk alternative to Isotretinoin, a derivative of Vitamin A.
0 Komentar untuk "Zolav®: New, Promising Antibiotic for Treatment of Acne"